Apparently Yale cancelled the conference at ASCO they might have presented preliminary trial results at. Not sure why they would cancel apparently at the last minute. A poster on Ozestock "Halcyon" found two conferences on the ASCO website and then just before the conference one was gone (the one that looked like presenting on clinical results).
Now, ASCO is the biggest conference for cancer anywhere in the world. If you were going to release preliminary results I would assume you would do it there or not at all. Unfortunately my timeline has slipped on this and I think we'll see the results only when the trials are finished i.e. Jan/Feb next year.
But this doesn't mean the price will plummet like it has in the past. Fundamentally Novogen is in very much better shape and has never looked better. Traders might be net sellers at the moment but longs are quite happy.
Cheers, Munch.
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
